Gynecologic cancers, such as endometrial cancer (EC), ovarian cancer (OC), and cervical cancer (CC), are frequently characterized by the dysregulation of the PI3K, AKT, and mTOR (PAM) pathway. This evidence concerns the gene PIK3CB and ovarian cancer.